3B Future Health Fund — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.
BiotechHouston, US
Alice Bexon(Executive Officer)Clifford J. Stocks(Director, Executive Officer)Kamal D. Puri(Executive Officer)Chris Russell(Executive Officer)Russ Hawkinson(Executive Officer)
BoardSteven Gillis(Director)in
Board seatRoberto De Ponti· per SEC Form D
Co-investorsCanaan PartnersGreatPoint VenturesRiverVest Venture PartnersARCH Venture PartnersQatar Investment AuthorityYonjin Venture LLC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.